HC Wainwright & Co. Maintains Buy on Instil Bio, Raises Price Target to $25
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and raises the price target from $18 to $25.
HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and raises the price target from $18 to $25.